Credit Suisse’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-57,477
| Closed | -$305K | – | 3050 |
|
|
2023
Q3 | $305K | Sell |
57,477
-20,795
| -27% | -$110K | ﹤0.01% | 2920 |
|
|
2023
Q2 | $746K | Buy |
78,272
+42,775
| +121% | +$408K | ﹤0.01% | 2563 |
|
|
2023
Q1 | $390K | Buy |
35,497
+11
| +0% | +$121 | ﹤0.01% | 2862 |
|
|
2022
Q4 | $525K | Buy |
35,486
+633
| +2% | +$9.37K | ﹤0.01% | 2736 |
|
|
2022
Q3 | $665K | Buy |
34,853
+17,112
| +96% | +$326K | ﹤0.01% | 2600 |
|
|
2022
Q2 | $378K | Buy |
17,741
+502
| +3% | +$10.7K | ﹤0.01% | 3007 |
|
|
2022
Q1 | $331K | Sell |
17,239
-404
| -2% | -$7.76K | ﹤0.01% | 3161 |
|
|
2021
Q4 | $366K | Buy |
17,643
+652
| +4% | +$13.5K | ﹤0.01% | 3210 |
|
|
2021
Q3 | $406K | Buy |
16,991
+2,367
| +16% | +$56.6K | ﹤0.01% | 3117 |
|
|
2021
Q2 | $400K | Sell |
14,624
-2,053
| -12% | -$56.2K | ﹤0.01% | 3140 |
|
|
2021
Q1 | $482K | Sell |
16,677
-7,941
| -32% | -$230K | ﹤0.01% | 2971 |
|
|
2020
Q4 | $692K | Buy |
+24,618
| New | +$692K | ﹤0.01% | 2804 |
|